Locations and blueprints reveal massive nuclear expansion, with unclear ramifications for ongoing Russian offensives in Ukraine.

All four reasons remain valid after the FY25 results, which explains why the Catapult share price has gone from around $4.30 to $5.30 (at the time of writing). That’s an increase of about $270 million ...

When I last covered IPD Group (ASX: IPG), I argued that the share price looked interesting at around $3.70, because I thought the market had overreacted to the disappointing earnings guidance for H1 ...

Insider buying can be one of the more useful signals for investors to keep an eye on, particularly when the trades are on-market, voluntary, and funded with cold, hard cash. It’s no silver bullet, of ...

Liberal loss of Bradfield on Sydney’s North Shore - formerly held by Liberal Moderate - puts last week’s leadership vote in doubt.

Rumours of Greens demise after leader Adam Bandt's loss are exaggerated, but the party no longer wins second preferences as well as the ALP.

Insurers in the United States have picked up on a stark new epidemiological trend: young and middle-aged adults are dying more often than before. What insurers call “excess mortality” – the number of ...

The surprisingly decisive federal election result on Saturday has the Liberal-National (and Greens) camps looking around for answers. One Liberal Senator, Jane Hume, sees the same issues as the party ...

Ketamine will be available under Medicare and the Pharmaceutical Benefits Scheme (PBS) for treatment-resistant depression. It will be administered as a nasal spray under the brand name Spravato. It ...